Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. - Wikidata - wikimedia - TriplyDB

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

http://www.wikidata.org/entity/Q34100603

about

"Liquid biopsy"-ctDNA detection with great potential and challenges Epigenetics in diagnosis of colorectal cancer Septin Mutations in Human Cancers Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity Methylation of cell-free circulating DNA in the diagnosis of cancer Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature.Variants of a Thermus aquaticus DNA polymerase with increased selectivity for applications in allele- and methylation-specific amplification.Circulating Tumor DNA as Biomarkers for Cancer Detection.Prognostic and predictive biomarkers: tools in personalized oncology.Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer.Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany.Complete genes may pass from food to human blood.Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer.Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.Blood-based protein biomarker panel for the detection of colorectal cancer Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology A two-gene blood test for methylated DNA sensitive for colorectal cancer.Predictive Levels of CD24 in Peripheral Blood Leukocytes for the Early Detection of Colorectal Adenomas and Adenocarcinomas.Septin functions in organ system physiology and pathology.Aberrant methylation patterns in cancer: a clinical view.Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies.Screening of potential diagnostic markers and therapeutic targets against colorectal cancer.Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma.Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review.Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia.Clinical relevance of CDH1 and CDH13 DNA-methylation in serum of cervical cancer patients.Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients.Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer.Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker.Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection.Circulating methylated septin 9 nucleic Acid in the plasma of patients with gastrointestinal cancer in the stomach and colon.

P2860

Q26779222-6DE38232-0146-431B-81C6-F0FAC6E686DB Q28071714-159BA940-378B-47EA-ABCE-7C69F3BEDEB8 Q28078227-520D060C-AACF-4CA3-AD7D-CECC9CBA63DA Q28079672-A6461628-E90E-45A2-AE5F-B8AEC78521FD Q28080256-35C4C837-B28D-4A61-8541-994F6C0EAC0F Q28085699-411C9B31-BF3F-4DC4-8C69-4A3EC503A077 Q31103365-38D2832F-9E7B-4793-8D6D-0914907A2A26 Q33560085-60C42A39-4CFA-48D7-B3DB-40CDBEA0ED15 Q33573008-A9EEA69E-CE08-4C57-92D7-68F0B12CA75E Q33632125-5853BB23-E5BA-42F2-BCFA-02EDCA98FB8F Q33651583-E3DCAE5A-29C1-40F0-BC57-AD61FC5BA59A Q33716769-B28C8446-5DD9-48C6-9438-E456084E6BF7 Q34441837-92289B86-4EEF-4945-8A63-F889EB47C29A Q34487177-A5D73A25-8A66-43DA-904D-CD6E69156118 Q34500078-318A77EF-ACD2-4E71-AB09-79CD228B2235 Q34744294-38B82474-55B4-466B-878C-1E7F2CDD11A6 Q34874076-026B188E-6A05-4257-857D-207B8F799C5B Q34921290-1F4D948C-9243-44E2-97D4-8FD1944A233C Q34998496-E6332854-EEFA-4F17-A874-9EED6CBC714A Q35138892-AD796529-C9CD-4461-A2D6-71BEDE95D986 Q35152312-1CA6F9B2-7239-4EFF-A330-379DA0F9AD22 Q35202822-1D68DDF6-F309-41BB-87E5-134A5381CB3F Q35543094-D1090CFC-78B5-4BCB-991F-FA95533F18E9 Q35558499-012A067A-2EFE-4F15-8984-646093C03F2F Q35640681-90685A35-F81E-43A1-A783-ABD9997B774A Q35673813-FFCA6408-27F9-4373-A089-3B5FFAA7F32D Q35750355-AEEEBD7B-F99B-44D6-8345-5E876DED851A Q35780915-353D3DAB-01E6-45C2-873C-DDFDB4A805F4 Q35848462-2C2248B2-FB02-47F9-8464-29A75D36C118 Q35940554-7BDCF68C-40F3-416D-8CA1-2E7986C89CA1 Q36012080-226E5569-ED3B-499C-8E8C-5EF49C88D28A Q36120837-C7E03621-0889-405A-AFD2-F04F81D417E7 Q36131264-A63BC051-9079-44F3-AD7B-FA79C665D4E3 Q36197208-D6672F7A-1538-449B-BC43-7989BC9992CE Q36257990-570D1306-01E8-49A3-BAB6-1C107B708816 Q36293011-92FD06B6-0169-41EA-8831-E13EDFE17F2B Q36393854-A1DA54AF-11F8-4959-805E-A5B5A5F1ACE9 Q36404028-3BB1CB8F-E953-450F-92F4-DFAE6BB53230 Q36646536-130D2337-2C76-4D14-822B-A53AA47116C3 Q36865038-55E720DC-8FC1-41CF-8506-F2644B51E2BC

P2860

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

http://www.wikidata.org/entity/Q34100603

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

@ast

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

@en

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

@nl

type

label

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

@ast

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

@en

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

@nl

prefLabel

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

@ast

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

@en

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

@nl

P1433

Q34100603-BFD1FEEA-5F36-4DBD-8952-11A21F107206

P1476

Q34100603-9DF07948-7E6C-4703-85B8-601CF55583F5

P2093

Q34100603-14931114-0C37-4771-B664-564256652668

Q34100603-1EAD97C4-25C4-4592-9761-0587FE48DF9F

Q34100603-4D5D8524-4511-40E6-A193-D8A3CEEBAA22

Q34100603-8638E390-F6FC-49D4-9DC3-7A44F88B805F

Q34100603-8D6E06E6-AD94-4052-97C0-BC0782CD1DD3

Q34100603-A99BB1FD-9FE0-4A4A-96B4-ABB4413A93A4

Q34100603-CBD37DC5-F163-469F-A10F-B4D3482EE646

Q34100603-DA108D2D-3961-44AC-BCA5-0481B55C6ECD

Q34100603-FCB168FD-96AB-4B18-97AB-76D8A78A0058

P2860

Q34100603-032AC5D6-2CBF-49AA-990F-909A243C24C9

Q34100603-0DB8BF63-D81B-45DB-86AD-43B972B270D5

Q34100603-1BADA7D5-8199-4CDD-8023-B08E219B5975

Q34100603-1CA51CD7-B9CC-4C9B-BD0A-F52B2569CC21

Q34100603-2610BCE7-4376-4F88-8B41-11652538E73A

Q34100603-2A4B2C45-B072-4FA2-8405-093373C66379

Q34100603-37557FF6-85EA-4FD7-8F75-A1368E405D34

Q34100603-69C89E3F-CA2B-4141-8A5A-F2B7FA711049

Q34100603-6E70E92A-A6B8-407E-A5E7-0CD345A3A790

Q34100603-74E22D0D-0270-4DBF-A932-F5EFE2B40112

P2888

Q34100603-5E2293B2-C17C-4A5B-B221-26A245F7F8D7

P304

Q34100603-E9D122CA-DD82-4CBA-AB24-F3C40A9C3A38

P31

Q34100603-8FF2CC4F-DF82-411A-B92A-E2580301B193

P356

Q34100603-9604EDA0-4E1E-4F75-AA6D-663EB04A1ED7

P407

Q34100603-1E299CF9-F358-4C4B-A0D5-7FBD85A9FB5E

P478

Q34100603-83D66A1A-A62B-4D6B-B3D3-5BE645916E09

P577

Q34100603-E187527B-30D6-4D52-B19C-9813E5F87869

P5875

Q34100603-DCC26FAE-DB93-453C-891B-C4715271DF21

P6179

Q34100603-08950271-825F-468B-8423-3EC9382F715D

P698

Q34100603-854A9F7D-AABA-4AE6-B59F-00774BE4AF82

P921

Q34100603-51A0A4FA-0AE9-4C60-9769-0DAAB6AF12C0

P932

Q34100603-9D6EC7E7-5E5D-498A-8D97-BF42B2BE0712

P356

1741-7015-9-133

P1433

P1476

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.

@en

P2093

Ashley M Bunker

http://www.w3.org/2001/XMLSchema#string

Cecily P Vaughn

http://www.w3.org/2001/XMLSchema#string

John C Fang

http://www.w3.org/2001/XMLSchema#string

Jorja D Warren

http://www.w3.org/2001/XMLSchema#string

Karen A Heichman

http://www.w3.org/2001/XMLSchema#string

Larissa V Furtado

http://www.w3.org/2001/XMLSchema#string

Wade S Samowitz

http://www.w3.org/2001/XMLSchema#string

Wei Xiong

http://www.w3.org/2001/XMLSchema#string

William L Roberts

http://www.w3.org/2001/XMLSchema#string

P2860

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay

Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer

Two-sided confidence intervals for the single proportion: comparison of seven methods

Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions

Randomised study of screening for colorectal cancer with faecal-occult-blood test

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

CT colonography may improve colorectal cancer screening compliance.

DNA methylation biomarkers for blood-based colorectal cancer screening.

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007.

P2888

1741-7015-9-133

P304

133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1741-7015-9-133

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51877158

http://www.w3.org/2001/XMLSchema#string

P6179

1035285731

http://www.w3.org/2001/XMLSchema#string

P698

22168215

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3271041

http://www.w3.org/2001/XMLSchema#string